Kazuaki Harada

Presentation(s):

• SO-30: Impact of single heterozygous UGT1A1 on the clinical outcomes of nano-liposomal irinotecan plus 5-fluorouracil/leucovorin for patients with pancreatic ductal adenocarcinoma

  Friday, July 1, 2022
  18:13 – 18:21